Latest Product Launches News

Barramundi Limited’s portfolio took a heavy hit in Q1 2026, with a 15.4% adjusted NAV decline amid AI disruption anxieties and geopolitical tensions. The fund responded by trimming tech holdings and adding miners BHP and Rio Tinto, betting on copper demand and scale advantages.

Icetana AI reported a 51% year-on-year jump in annual recurring revenue to $2.6 million but faced a $1.2 million net operating cash outflow in Q3 FY26, prompting plans for a capital raise amid expected cash flow improvements.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

Wrkr Ltd has successfully launched its Rest Pay and AustralianSuper platforms, onboarding over 6,000 organisations and processing $100 million in contributions as it prepares for the July 2026 Payday Super legislative deadline.

Structural Monitoring Systems Plc reported a 55% jump in quarterly free cash flow to $1.4 million and eliminated its bank debt by repaying a C$0.8 million term loan. The company also launched the MTP138 radio targeting offshore markets and secured key certifications for its avionics products.

Ainsworth Game Technology’s FY25 results reveal a mixed bag: a 9% dip in underlying profit to $21.1 million, a hefty $43.1 million goodwill impairment tied to North America, and a strategic pivot with a new acting CEO. Strong Asia Pacific growth and new product launches contrast with margin pressures and a shrinking cash position.

Judo Bank reported solid Q3 lending growth and stable asset quality, maintaining its FY26 profit before tax guidance between $180m and $190m despite increasing credit loss provisions due to economic uncertainty.

Pureprofile delivered a robust Q3 FY26 with 17% revenue growth and a 67% spike in EBITDA, driven by strong international demand and a doubling of platform revenue. The company reaffirmed its FY26 guidance amid ongoing macroeconomic caution.

Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.

MyEco Group has locked in $0.92 million through its Series 2 convertible note program, reinforcing its growth trajectory with funding earmarked for a new GRS-certified recycled bin liner range. The raise supplements a solid cash position while aiming to limit shareholder dilution amid challenging market conditions.